[EN] COMPOUNDS AS RAS INHIBITORS AND USES THEREOF<br/>[FR] COMPOSÉS EN TANT QU'INHIBITEURS DE RAS ET LEURS UTILISATIONS
申请人:BIOARDIS LLC
公开号:WO2022087624A1
公开(公告)日:2022-04-28
The present disclosure relates generally to compounds and compositions thereof for inhibition of RAS, such as KRAS, HRAS and NRAS, including mutant forms of KRAS, HRAS and NRAS, particularly those harboring a G12C mutation, methods of preparing said compounds and compositions, and their use in the treatment or prophylaxis of various cancers, such as lung cancer, colorectal cancer, pancreatic cancer, gall bladder cancer, thyroid cancer, and bile duct cancer.
Syndiotactic- and heterotactic-specific radical polymerizations of N-n-propyl-α-fluoroacrylamide and phase-transition behaviors of aqueous solutions of poly(N-n-propyl-α-fluoroacrylamide)
further enhanced in radicalpolymerization of NNPFAAm. The effects of stereoregularity on the phase‐transition behaviors of aqueoussolutions of poly(NNPFAAm) were also investigated. Different tendencies in stereoregularity were observed in aqueoussolutions of poly(NNPFAAm)s from those in solutions of the hydrocarbon analogs such as poly(NIPAAm) and poly (NNPAAm). The polymerization behavior of NNPFAAm